Anti-D IgG was injected into 15 Rh-negative women in the 28th week of gestation and into three non-pregnant women. The uptake of anti-D after the intramuscular injections was calculated by measuring the concentration of antibody in the plasma with an autoanalyser. The biological half life and the catabolic rate of anti-D IgG were calculated according to a compartmental model. The recovery in vivo of anti-D IgG was on average 24% in the non-pregnant women and 21% in the pregnant women. The half lives of anti-D IgG were 24 and 21 days, respectively. With a dose of 125 ,ug the plasma anti-D concentration was less than 1 ng/ml at about 10 weeks after the injection. With double the dose the concentration at delivery was at least 1 ng/ml.Although 250 ,ug of anti-D IgG seems to be effective when given in the 28th week of gestation, the great individual variations in uptake and recovery rates will lead to occasional cases of Rh-immunisation during pregnancy despite all routine regimens.
IntroductionThere is good evidence that giving anti-D immunoglobulin both antenatally and at delivery has substantially reduced the incidence of Rh-immunisation.1-3 Moreover, when antenatal treatment with anti-D IgG is indicated a single dose of 250 ,ug in the 28th week of gestation is effective. A smaller dose and a different timing may be just as adequate and more economical but have not been tried.Since there is almost no information available on the biological half life of anti-D IgG, which determines the effectiveness of different dose-schedules, we studied this question in pregnant and non-pregnant women.